title: Serum zinc, insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with type 1 diabetes mellitus.
abstract: BACKGROUND
  Growth is impaired during the course of diabetes mellitus (DM). Derangement of the growth hormone/insulin-like growth factor (IGF) axis, insulinopenia and zinc deficiency are the possible causative factors of this impairment. Zn supplementation is proven to attenuate hyperglycemia in mice but its use to ameliorate impaired height is still a matter of discussion.
  
  
  OBJECTIVE
  To investigate serum Zn, IGF-I and IGF binding protein-3 (IGFBP-3) levels and to emphasize the potential beneficial effects of Zn supplementation for the prevention of growth failure in children with type 1 DM (DM1).
  
  
  METHODS
  Twenty-eight patients with DM1 and 15 control children were included in the study. Zn levels were measured by flame atomic absorption spectrophotometry; IGF-I and IGFBP-3 levels were measured by immunoradiometric assay.
  
  
  RESULTS
  Mean serum Zn levels were significantly lower in diabetic children taken as a whole and as their pubertal subgroup compared to the controls. Mean serum IGF-I and IGFBP-3 levels were significantly lower in both prepubertal and pubertal diabetic groups compared to those of control groups.
  
  
  CONCLUSIONS
  From the results of our study, it can be hypothesized that serum Zn levels should be closely monitored during the course of DM1 and supplementation may be given to patients, especially at the time of puberty. This hypothesis needs to be confirmed by further studies.
authors.affiliation: Department of Pediatric Endocrinology, Gazi University, Ankara, Turkey. turkalpo@yahoo.com
authors.forename: Aysun
authors.initials: A
authors.lastname: Bideci
authors.forename: M Orhun
authors.initials: MO
authors.lastname: Camurdan
authors.forename: Peyami
authors.initials: P
authors.lastname: Cinaz
authors.forename: Hasan
authors.initials: H
authors.lastname: Dursun
authors.forename: Fatma
authors.initials: F
authors.lastname: Demirel
mesh_terms: D000293:Adolescent; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D015592:Immunoradiometric Assay; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D011627:Puberty / Q000502:physiology; D013054:Spectrophotometry, Atomic; D015032:Zinc / Q000008:administration & dosage / Q000097:blood*
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I; D015032:Zinc